4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-034673
SrVP/CFO/Prin Fin & Acct Ofcr bought 1,010 shares at $7.29 ($7,363)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2024-03-13 | Purchase | +1,010 | $7.29 | $7,363 | 15,503 | D |
| Derivatives | |||||||
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2024-03-13 | Purchase · Tranche A Warrant | +505 | 505 | D | ||
| Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | 2024-03-13 | Purchase · Tranche B Warrant | +505 | 505 | D | ||
| Open-market purchases · 1,010 sh · avg $7.29 · $7,363 | |||||||
Loading xslF345X05/tm248935-4_4seq1.xml…